QCIL Stock Overview
A pharmaceutical manufacturing company based in Uganda, produces treatments for HIV/AIDS, malaria, hepatitis, and other medical conditions. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Quality Chemical Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | USh87.00 |
| 52 Week High | USh87.00 |
| 52 Week Low | USh55.00 |
| Beta | -0.17 |
| 1 Month Change | 0% |
| 3 Month Change | 11.54% |
| 1 Year Change | 58.18% |
| 3 Year Change | 8.75% |
| 5 Year Change | -13.86% |
| Change since IPO | -66.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| QCIL | UG Pharmaceuticals | UG Market | |
|---|---|---|---|
| 7D | 0% | -1.7% | 0.05% |
| 1Y | 58.2% | -28.2% | 30.5% |
Return vs Industry: QCIL exceeded the UG Pharmaceuticals industry which returned -29% over the past year.
Return vs Market: QCIL exceeded the UG Market which returned 30.6% over the past year.
Price Volatility
| QCIL volatility | |
|---|---|
| QCIL Average Weekly Movement | 2.3% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 2.5% |
| 10% most volatile stocks in UG Market | 3.3% |
| 10% least volatile stocks in UG Market | 1.5% |
Stable Share Price: QCIL has not had significant price volatility in the past 3 months compared to the UG market.
Volatility Over Time: QCIL's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 362 | Ajay Pal | www.qcil.com |
Quality Chemical Industries Limited, a pharmaceutical manufacturing company based in Uganda, produces treatments for HIV/AIDS, malaria, hepatitis, and other medical conditions. The company offers a range of products, including antibacterials, antihypertensives, vasodilators, antiemetics, antibiotics, and antidiabetic medications. Specifically, it provides Lamivudine/Tenofovir Disoproxil Fumarate, Dolutegravir, Efavirenz, and Zidovudine tablets for the treatment of HIV infection.
Quality Chemical Industries Limited Fundamentals Summary
| QCIL fundamental statistics | |
|---|---|
| Market cap | USh317.72b |
| Earnings (TTM) | USh40.65b |
| Revenue (TTM) | USh267.13b |
Is QCIL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QCIL income statement (TTM) | |
|---|---|
| Revenue | USh267.13b |
| Cost of Revenue | USh158.64b |
| Gross Profit | USh108.49b |
| Other Expenses | USh67.83b |
| Earnings | USh40.65b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 11.13 |
| Gross Margin | 40.61% |
| Net Profit Margin | 15.22% |
| Debt/Equity Ratio | 0% |
How did QCIL perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/21 02:42 |
| End of Day Share Price | 2025/05/21 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Quality Chemical Industries Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.